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Abstract
Background: Many children with cancer are diagnosed during infancy and toddlerhood (<3 years
of age), potentially resulting in disrupted and/or missed developmental opportunities. Diagnoses
that affect the central nervous system are among the most common and are associated with an
increased risk of neurocognitive problems. Unfortunately, there is a paucity of research regarding
the functioning of very young children treated for cancer. The objective of this study was to
describe the cognitive, adaptive, and psychosocial functioning of infants and toddlers with cancer
evaluated at a hospital-based psychology clinic. Method: Data from 32 infants and toddlers with
cancer and/or immunological disorders (Mage = 24.6 ± 6.6 months; 56.3% male) who completed
clinically-referred assessments in a hospital psychology clinic from 2010-2015 were abstracted.
Indicators of cognitive, adaptive, and psychosocial functioning were collapsed across measures
prior to analyses. Results: Infants and toddlers were 13.32 months post-diagnosis (SD = 9.12,
range 0 - 34.44 months) with a majority off-therapy at the time of assessment (59.4%). The
majority of patients had brain (28.1%) or solid tumors (46.9%). Mean early cognitive scores
were significantly below expectations, t(24) = -9.02, p < .001. Adaptive functioning, t(27) = 7.03, p < .001 and some indices of psychosocial functioning were also significantly below
expectations. Differences in early cognitive functioning were present based on diagnostic
category but not treatment status. Conclusion: Infants and toddlers with cancer appear to be at
significant risk for weaknesses in cognitive, adaptive, and psychosocial functioning, though
some domains within psychosocial functioning are preserved. The surprising severity of deficits
warrant the need for further investigation and consideration of this population to ensure optimal
functional development.
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Cognitive, Adaptive, and Psychosocial Functioning of Infants and Toddlers Treated for
Cancer
Infancy and toddlerhood mark the largest developmental changes during the human
lifespan, concurrent with a time of significant brain development (Casey, Giedd, & Thomas,
2000; Jernigan, Baaré, Stiles, & Madsen, 2011; Stiles, 2008). Specifically, very young children
rapidly acquire skills across cognitive, adaptive and psychosocial domains. To achieve optimal
development, infants and toddlers require predictability, consistency, reciprocal interactions,
warmth, perceived security, and opportunities to explore and experiment within their
environment (National Research Council and Institute of Medicine, 2000). Recent advances in
neuroscience have increased understanding of the pivotal role of early social interactions in brain
development (Meltzoff & Kuhl, 2016). Interruption and insult during this critical period, such as
a cancer diagnosis and required treatments, have the potential to result in significant and longlasting effects (Anderson & Kunin-Batson, 2009; Olsson, Perrin, Lundgren, Hjorth, & Johanson,
2014).
Many children with cancer are diagnosed and treated during infancy and toddlerhood
(Ward, DeSantis, Robbins, Kohler, & Jemal, 2014). As such, the ongoing development of these
very young children may be disrupted due to a number of factors, including isolation related to
treatment, prolonged stays in the hospital, medical procedures, and removal from typical
routines. This disruption may have the consequence of diminishing those essential needs for
social interaction, exploration, and predictability which may impact later development (see
Harman, Wise, & Willard, 2017 for a review). Fortunately, advances in treatment have
dramatically increased the survival rates of children with cancer over the past few decades
(Abdullah, Qaddoumi, & Bouffet, 2008). Subsequently, there has been an increased awareness of
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the need to understand the impact of treatment and diagnosis on the social, emotional,
behavioral, and overall developmental functioning of children with cancer.
Very young age at diagnosis is typically considered a significant risk factor for
development of later adverse problems (Mulhern et al., 2001). This is particularly true for
neurocognitive late effects in children with diseases and treatment that affect the central nervous
system (CNS; e.g., brain tumors, acute leukemias) (Moleski, 2000; Mulhern, Merchant, Gajjar,
Reddick, & Kun, 2004). Despite these risks, there is a paucity of literature on the cognitive and
psychosocial functioning of infants and toddlers treated for cancer. Existing research has focused
mainly on the potential for preserving neurocognitive functioning of young children under the
age of three through the avoidance of cranial radiation therapy (Dhall et al., 2008; Lafay-Cousin
et al., 2009). Limited work has also focused on the functional outcome of young children treated
for brain tumors. Specifically, Stargatt and colleagues (2006) investigated the cognitive and
adaptive development of children diagnosed with brain tumors during infancy and found delays
in multiple domains of adaptive function at diagnosis along with cognitive deficits during
follow-up at age 5 and 6. Similarly, Bornstein and colleagues (2012) prospectively studied the
neurodevelopment of very young children with non-CNS affecting cancers (i.e., retinoblastoma,
neuroblastoma, acute leukemia) and found deficits within motor, mental, and language skills
compared to healthy controls. Several recent papers (Fay-McClymont et al., 2017; Willard,
Leung, Huang, Zhang, & Phipps, 2014; Willard et al., 2014) have also highlighted the potential
vulnerabilities of this age range for deficits or declines in cognitive and adaptive functioning.
Specifically, Willard and colleagues (2014) longitudinally studied infants and toddlers with
retinoblastoma through their first 5 years of life and observed significant declines over time in
developmental and adaptive functioning (e.g., socialization, communication, and motor skills).
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Similarly, in a prospective longitudinal study, patients treated with total body irradiation
demonstrated declines in cognitive functioning (e.g., IQ) 1, 3, and 5 years following stem-cell
transplant (Willard, Leung, et al., 2014). Moreover, a retrospective study of young patients with
medulloblastoma treated with chemotherapy and irradiation sparing approach demonstrated
deficits across domains in a quarter of the sample regardless of prevention efforts via treatment
strategy (Fay-McClymont et al., 2017). Despite the salient findings of these few studies
providing evidence that very young children are at risk, there is still very limited research
regarding the cognitive and psychosocial functioning of this population. Subsequently, there is a
critical need for a more explicit focus across domains. Specifically, cognitive, communication,
adaptive behavior, social, emotional/behavioral, and motor skills are all areas of functioning that
could be affected by the developmental disruption of cancer treatment and thus lead to delays or
deficits.
Given the critical nature of infancy and toddlerhood on later development and the limited
cancer-specific research on this age range, the objective of this paper was to characterize the
cognitive, adaptive, and psychosocial functioning of very young children (under the age of three
years) treated for cancer. Using a clinical sample of children evaluated within a hospital-based
psychology clinic, we hypothesized that those patients with CNS-affecting diagnoses (e.g., brain
tumors) would demonstrate greater deficits in functioning across domains, though we also
expected that most children assessed would demonstrate emerging weaknesses in at least some
domains of functioning.
Spelled out: Consistent with previous albeit limited studies examining the cognitive and
adaptive outcomes of very young children treated for CNS-affecting cancers (Fay-McClymont et
al., 2017; Stargatt et al., 2006), it is hypothesized that patients with CNS-affecting diagnoses

3

(e.g., brain tumors) will demonstrate greater deficits in functioning across cognitive, adaptive,
and psychosocial domains. Moreover, consistent with the few studies that have investigated very
young children with non-CNS affecting cancers (e.g., solid tumors) (Bornstein et al., 2012;
Willard et al., 2014), it is hypothesized that most patients assessed will demonstrate emerging
weaknesses in at least some domains of functioning.
Research Question: Given the critical nature of infancy and toddlerhood on later
development and the very limited cancer-related research on this specific age range; what are the
characteristics of the cognitive, adaptive, and psychosocial functioning of very young children
(<3 year of age) treated for cancer?
Hypotheses: Patients with diagnoses that affect the central nervous system (e.g., brain
tumors) will demonstrate greater deficits in functioning across cognitive, adaptive, and
psychosocial domains, relative to patients with other types of cancer.
Most patients assessed will demonstrate emerging weaknesses in at least some domains
of functioning regardless of diagnostic category (brain tumor versus solid tumor).
Method
Participants
The sample for this study included 32 very young children under the age of 36 months (M
= 24.6 ± 6.6 months). The majority of patients were male (n = 18, 56.3%) and Caucasian (n = 22,
68.8%). All primary diagnostic categories were represented, including solid tumors (n = 15,
46.9%), brain tumors (n = 9, 28.1%), leukemias (n = 4, 12.5%), and non-malignancies treated
with bone marrow transplant (n = 4, 12.5%). The most common diagnosis was retinoblastoma (n
= 10, 31.3%). The majority of patients were off-therapy at the time of assessment (n = 19,
59.4%) with an average of 10.78 ± 7.75 months off therapy, and a mean of 13.32 months since
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diagnosis (median = 11.4, SD = 9.12, 0 - 34.44 months). Treatment plans varied with a majority
of patients receiving chemotherapy (n = 23, 71.9%). Notable was one patient with a premorbid
diagnosis of Down syndrome and another with 13q deletion syndrome, both associated with
developmental and learning difficulties (Baud et al., 1999; Grieco, Pulsifer, Seligsohn, Skotko, &
Schwartz, 2015). Less than a third of patients (n = 9, 28.1%) received a psychological diagnosis
of cognitive disorder not otherwise specified, unspecified delay in development, or mixed
development disorder following their assessment. See Table 1 for more detailed demographic
and treatment information.
Measures
Cognitive functioning. Two measures were utilized by clinicians to assess early
cognitive functioning with 29 (90.6%) patients administered such a measure during their
evaluation. Most patients were administered the Mullen Scales of Early Learning (n = 18;
Mullen, 1995) with the remaining administered the Bayley Scales of Infant and Toddler
Development, Second Edition (n = 11; Bayley, 1993). For analytical purposes, the primary
indices of interest that were collapsed across measures included Cognitive Composite, Gross
Motor, Fine Motor, Expressive Language, and Receptive Language. The Cognitive Composite
for both measures is presented as a Standard Score (M = 100, SD = 15). Scores for the other
subscales – initially presented as T-scores or scaled scores – were converted to standardized zscores using the standard normative mean for comparison purposes. The Mullen demonstrates
satisfactory internal consistency with a high median value of .91 for cognitive composite (early
learning) and other domains median values ranging from .75 - .83, as well as good construct
validity (Mullen, 1995). The Bayley correlates with other cognitive instruments and is sensitive
to performance differences in normative samples and samples at risk for delays with good to
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excellent internal consistency reliability coefficients ranging from .86 (fine motor skills) to .91
(cognitive composite and gross motor skills) (Bayley, 1993).
Adaptive functioning. Adaptive functioning was assessed via the parent-report versions
of the Vineland Adaptive Behavior Scales, Second Edition (VABS-2; Sparrow, Cicchetti, &
Balla, 2005) and the Adaptive Behavior Assessment System, Second Edition (ABAS-2; Harrison
& Oakland, 2003). Most patients (n = 29: 48.3% ABAS-2) completed an adaptive measure as
part of their battery. Similar scores across these two measures included an overall Adaptive
Functioning Composite as well as indicators of Socialization, Communication, Daily Living, and
Motor Skills. Given differences in standardized scores available for these two measures, the
scaled scores for Communication and Motor Skills in the ABAS-2 were converted to standard
scores in order to compare across measures. Internal consistency reliability coefficients range
from .81 (motor skills – scale) to .97 (adaptive composite) for the ABAS-2 and is equally reliable
for assessing individuals with different clinical diagnoses (Harrison & Oakland, 2003). The
VABS-2 demonstrates good to excellent reliabilities ranging from .89 (daily living composite) to
.97 (adaptive composite) with supported evidence of construct validity and correlates with the
ABAS-2 (Sparrow, Cicchetti, & Balla, 2005). See Table 2 for a more detailed list of internal
consistency reliabilities measured by coefficient alpha for parent-report measures.
Psychosocial functioning. Psychosocial functioning was assessed for nearly half of the
patients (n = 14) via two parent-report measures. Most parents (85.7%) completed the Child
Behavior Checklist (CBCL; Achenbach, 1991) and the remainder completed the Behavior
Assessment System for Children, Second Edition (BASC-2; Reynolds & Kamphaus, 2004).
Domains consistent across these measures included indicators of Internalizing Behavior,
Externalizing Behavior, Aggression, Anxiety, Withdrawal, Somatization, Attention Problems,
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and Pervasive Developmental Problems. All scores are presented as age-standardized T-scores
(M = 50, SD = 10). The CBCL consistently demonstrates good construct validity and internal
consistency coefficients are high for internalizing and externalizing (.90 and .94, respectively) as
well as between good and excellent for most of the subscales (α = .75 - .94) (Achenbach, 1991).
Internal consistency reliabilities measured by coefficient alpha for the BASC-2 range from .77
(anxiety – scale) to .87 (externalizing behavior – composite). Further, the BASC-2 correlates
with other scales that reflect current behavioral dimensions (Reynolds & Kamphaus, 2004). See
Table 2 for a more detailed list of measure reliabilities.
Procedure
Cognitive and psychosocial assessment data of infants and toddlers with cancer were
retrospectively abstracted from the medical records of a pediatric-focused cancer institution. All
participants completed a clinically-referred assessment in a hospital-based psychology clinic
between 2010 and 2015. Participants were eligible for this study if they were under the age of
three years at the time of assessment and diagnosed with a malignancy and/or a non-malignancy
treated with bone marrow transplant. Institutional Review Board approval was obtained prior to
data abstraction. Overall, 32 infants and toddlers met inclusion criteria for this study.
Data abstracted from the medical charts included demographic (e.g., age, race, gender)
and medical (e.g., diagnosis, treatment) information. The psychological assessment data included
measures of early developmental, adaptive, and psychosocial functioning. As all data were
clinically collected, the present study was limited to the measures chosen by individual
clinicians, rather than a standard battery. Assessment data were collapsed and combined across
similar measures and domains when possible.
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Analytical Plan
Descriptive statistics were used to characterize the sample for each domain including
mean, standard deviation, and percentage in the at-risk or clinically significant range, which are
operationalized as one and two standard deviations above or below the normative mean –
depending on the measure. The mean scores for participant functioning in each domain were
compared to the published normative mean for each measure using one-sample t-tests.
Independent samples were used to examine differences in functioning based on clinicallyrelevant risk factors: diagnostic category (brain tumor versus solid tumor) and treatment status
(on-therapy versus off-therapy) and when sample size in a group was less than 9, we elected to
use non-parametric statistics – in this case the Mann-Whitney U test. Finally, differences among
group means for the early cognitive composite and overall adaptive composite were examined by
gender as well as whether a psychological diagnosis was assigned, deferred, or not given using
analysis of variance (ANOVA).
Results
Descriptive Analyses
One-sample t-tests and mean scores for all domains are available in Table 3 (cognitive
functioning) and Table 4 (parent-reported adaptive and psychosocial functioning). All cognitive
domains were significantly below the normative mean. For the cognitive composite, a majority
of patients achieved scores that fell one or two standard deviations below the mean (44% and
20%, respectively) with average scores significantly below normative expectations [M = 78.12,
SD = 12.13, t(24) = -9.02, p < .001]. A majority of patients (80%) achieved scores in the
extremely low to low average range with no patients in the high average to superior ranges. For
all domains of cognitive functioning, significantly more patients than would be expected fell one
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and/or two standard deviations below the normative mean (27.0 - 44.0% and 19.2 - 40.0%,
respectively).
Overall, parent-reported adaptive functioning scores were also lower than would be
expected (Table 4). For all domains of adaptive functioning, significantly more patients than
would be expected fell one and/or two standard deviations below the normative mean (21.5 39.1% and 17.2 - 32.1%, respectively). The average overall adaptive functioning composite
score was significantly below normative expectations [M = 78.89, SD = 15.88, t(27) = -7.03, p <
.001] with patients averaging in the delayed (i.e., low) range. Scores were also significantly
below normative expectations for the social, daily living, communication, and motor skills
composites (Table 4).
In contrast, parent-reported psychosocial functioning was generally within normal limits,
with a majority of mean scores falling within the average range (Table 4). However, mean scores
for aggression [M = 55.07, SD = 6.12, t(13) = 3.10, p = .008], somatization [M = 55.00, SD =
8.71, t(13) = 2.15, p = .05], attention problems [M = 57.57, SD = 8.91, t(13) = 3.18, p = .007],
and pervasive developmental problems [M = 60.77, SD = 11.51, t(12) = 3.38, p = .006] were
significantly above the normative mean, indicating more problems than would be expected.
Further, all domains within psychosocial functioning had at least one patient fall within the atrisk and/or clinically significant elevation range (7.1 - 35.7% and 7.1 - 23.1%, respectively).
Predictors of Functioning
Non-parametric analyses using the Mann-Whitney test were completed to compare
patients based on diagnostic category and treatment status on the cognitive and adaptive
composites. Results revealed a statistically significant difference in the cognitive composite
based on diagnostic category [U(19) = 23.5, p = .02] with patients with solid tumors

9

demonstrating significantly greater cognitive scores (Mdn = 84) than those with brain tumors
(Mdn = 75). In contrast, results indicated that there was not a significant difference in parentreported adaptive functioning based on diagnostic category between patients with brain tumors
(Mdn = 68) and solid tumors (Mdn = 87), [U(20) = 38.5, p = .14]. Further, there were no
significant differences for cognitive [on: Mdn = 82; off: Mdn = 76, U(24) = 62, p = .29] or
adaptive functioning [on: Mdn = 85.5; off: Mdn = 74.5, U(27) = 90, p = .39] based on treatment
status (on versus off) at the time of assessment.
Results revealed no differences in functioning based on gender [Cognitive: F(1, 23) =
1.67, p = .21; Adaptive: F(1, 26) = 0.81, p = .38]. In contrast, there was a significant difference
between groups based on if a diagnosis was assigned, deferred, or not given following the
evaluation for overall adaptive functioning [F(2, 25) = 5.54, p = .01]. Specifically, those patients
who received a psychological diagnosis post-assessment had the lowest adaptive outcomes. In
contrast, there was not a significant difference between groups based on psychological diagnosis
for early cognitive functioning [F(2, 22) = 1.22, p = .32].
Discussion
The objective of the current study was to characterize the cognitive, adaptive, and
psychosocial functioning of clinically-referred infants and toddlers diagnosed with cancer. A vast
majority of our sample demonstrated clinically significant impairments in cognitive functioning.
Indeed, almost all patients in our sample exhibited below average cognitive functioning, with
none exceeding the average range. Consistent with this finding, a majority of our sample
demonstrated significant impairments in adaptive functioning. In contrast, psychosocial
functioning was broadly within normal limits, though several subscales – aggression,
somatization, attention, and pervasive developmental problems – were significantly greater than
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normative means. Functioning within overall cognitive and adaptive domains exhibited little
variance irrespective of diagnostic category, treatment status or gender, though patients with
brain tumors demonstrated significantly lower cognitive functioning as compared to patients
with solid tumors. While our sample was potentially biased by clinical referral, ultimately,
results suggest that infants and toddlers treated for cancer – irrespective of known risk factors –
potentially represent a population that may be predisposed to cognitive and psychological delays.
In contrast with expectations based on extant literature (Mulhern & Butler, 2004; Stargatt
et al., 2006), infants and toddlers with brain tumors did not consistently demonstrate more
adaptive difficulties than infants and toddlers with non-CNS diagnoses (i.e., solid tumor).
However, these findings are in keeping with more recent research that has demonstrated
cognitive and adaptive deficits in young children and toddlers treated for non-CNS diagnoses
(Bornstein et al., 2012; Willard, Leung et al., 2014; Willard, Qaddoumi et al., 2014). In
combination, these findings further assert the need for additional systematic longitudinal
assessment of functioning of young children with cancer, regardless of diagnosis. Certainly these
findings are in contrast with studies of older children, and suggest that very young children with
cancer may need to be viewed differently than older children. Indeed, given the potential
influence of insecure attachment, diminished predictability, and missed developmental
opportunities for infants and toddlers who spend their early years undergoing treatment, an
increased recognition and focus on infants and toddlers with cancer is critical.
Congruent with a need for further study is a need for early detection of deficits, which is
critical for early intervention and prevention efforts. Given the malleability of early
development, infants and toddlers may benefit from remediation or prevention of deficit through
increased referrals to early intervention services (Guarlnick, 2011; Harman, Wise, & Willard,
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2017; Hebbeler et al., 2007). Harman and colleagues (2017) recently highlighted the existing
evidence concerning the various developmental risk factors for children with cancer under three
years of age and the associated long-term sequelae. Given the provided evidence and as experts
in their respective fields, it is their recommendation that all infants and toddlers with cancer be
systematically referred for Early Intervention services as soon as possible after initial diagnosis.
Fortunately, state funding is provided for Early Intervention services for infants and toddlers
with developmental delays or those at risk for delays through Part C of the Individuals with
Disabilities Education Act (Individuals with Disabilities Education Act, 2004). These services –
which often includes rehabilitation services as well as psychological therapies for the child and
family – can be implemented within the hospital, community center, or home, depending on the
child and family’s need. Further, these early intervention services do not focus solely on the
infant/toddler, but rather engage in an efficacious family-centered approach to ensure optimal
developmental outcomes (Harman et al., 2017; Hebbeler et al., 2007).
This study has a number of limitations that should be noted. The biggest limitation is the
small sample size. Given the methodology of a retrospective chart review, we were constrained
by the sample that was assessed during our timeframe. Thus, analyses may be interpreted as pilot
data and had a larger sample size been available, the effects may have been more pronounced.
Further, our sample was clinically-referred. As such, there may be potential bias in regards to the
severity of the findings. Referrals to our psychology clinic are frequently made for routine
surveillance given the cognitive and adaptive risks for these patients (Bornstein et al., 2012;
Fouladi et al., 2005; Stargatt et al., 2006), though a portion of our sample was likely referred due
to clinician concern for developmental delays. Regardless, the significance of deficits within our
sample – most notably within cognitive functioning – was concerning and warranted report
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irrespective of this potential bias. Moreover, our findings are generally consistent with other
studies of infants and toddlers with brain tumors and retinoblastoma that were prospectively
followed (Fay-McClymont et al., 2017; Fouladi et al., 2005; Sands et al., 2010; Willard,
Qaddoumi, et al., 2014). Additionally, as all data were clinically-collected, the present study was
limited to those measures that were utilized which required collapsing and combining of scores
across measures, thus limiting sample size in some domains. This was particularly true for
measures of psychosocial functioning, which were infrequently administered. Given our
findings, and in keeping with recent practice standards (Kazak et al., 2015), we would
recommend that clinicians start systematically assessing psychosocial functioning in concert with
cognitive and adaptive functioning as early as possible. Finally, it is well known that
socioeconomic status, environment, and parent factors influence cognitive functioning and
developmental outcomes in young children (Kingston, McDonald, Austin, & Tough, 2015;
Nagayoshi et al., 2017; Caspi et al., 2016). However, this information was not accessible for our
sample as it is not systematically collected during clinical assessments at our institution.
Prospective studies should ensure collection of this information to determine if these factors play
a moderating role in the cognitive and psychosocial functioning of infants and toddlers treated
for cancer.
Results of this study highlight the potential vulnerability of infants and toddlers’
cognitive, adaptive, and psychosocial development when treated for cancer. Functional
weaknesses appear to be present irrespective of the traditional risk factors of diagnosis and
treatment status. Consequently, there is a strong need to better understand the developmental
trajectory of infants and toddlers treated for cancer – especially those with non-CNS affecting
diagnoses. Future research must prospectively assess these young patients and also seek to
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intervene in order to promote the best possible developmental outcomes. As such, future studies
must have an increased focus on adapting and applying intervention and prevention efforts.
Ultimately, further investigation of infants and toddlers treated for cancer is truly critical in order
to identify and address these core deficits as early as possible, thereby promoting normalized and
positive developmental trajectories of this population.
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Appendix A: Tables
Table 1. Demographic and treatment information (N = 32)
N (%)
Demographic Information
Gender
Male
Female
Race
White
Black
Other
Age at Assessment (months)
Mean
Standard Deviation
Range
Diagnostic and Treatment Information
Diagnostic Category
Solid Tumor
Brain Tumor
Leukemia
Non-malignancy
Age at Diagnosis (months)
Mean
Median
Standard Deviation
Range
Treatment
Surgery
Chemotherapy
Radiation Therapy
Transplant
Time Since Diagnosis (months)
Mean
Median
Standard Deviation
Range
Treatment Status
On Therapy
Off Therapy
Months Off Therapy
Psychological Diagnosis
Assigned
Deferred
Not Given

18 (56.3)
14 (43.8)
22 (68.8)
7 (21.9)
3 (9.4)
24.6
6.6
8.04 – 35.52

15 (46.9)
9 (28.1)
4 (12.5)
4 (12.5)
11.16
11.88
7.92
0 – 25.56
15 (46.9)
23 (71.9)
3 (9.4)
6 (18.8)
13.32
11.4
9.12
0 – 34.44
13 (40.6)
19 (59.4)
10.78 ± 7.75 (0 - 24.84)
9 (28.1)
12 (37.5)
11 (34.4)
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Table 2. Internal consistency: Coefficient alpha reliabilities of parent-report measures
Adaptive Functioning

Vineland-II

ABAS-II

Adaptive Composite

.97

.97

Social Composite

.93

.91

Communication Composite a

.92

.87

Daily Living Composite

.89

.93

Motor Skills Composite a

.90

.81

CBCL

BASC-II

Internalizing Behavior

.90

.85

Externalizing Behavior

.94

.87

Aggression

.94

.78

Anxiety

.84

.77

Withdrawal

.80

.82

Somatization

.75

.79

Attention Problems

.86

.86

*

*

Psychosocial Functioning

Pervasive Developmental Problems
a Domain

in Vineland-II, Scale in ABAS-II

* Not provided in CBCL or BASC-II manuals
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Table 3. Cognitive functioning
Cognitive Functioning

N

Mean ± SD

Range

t†

p

N (%) 1 SD

N (%) 2 SD

Cognitive Compositea

25

78.12 ± 12.13

55 – 100

-9.02

<.001

11 (44.0)

5 (20.0)

Gross Motor Skillsb

20

-1.69 ± .96

-3.00 – 0

-7.86

<.001

6 (30.0)

8 (40.0)

26

-1.45 ± 1.14

-3.00 – .40

-6.48

<.001

8 (30.7)

8 (30.8)

Expressive Language

26

-1.14 ± .86

-3.10 – 0

-6.73

<.001

7 (27.0)

5 (19.2)

Receptive Languageb

26

-1.11 ± 1.14

-3.00 – .67

-4.95

<.001

11 (42.3)

5 (19.2)

Fine Motor Skillsb
b

a

Standard score: normative mean = 100, SD = 15; 1 SD < 85, 2 SD < 70

b Standardized

z-score: normative mean = 0, SD = 1; 1 SD < -1, 2 SD < -2

† One-sample t-test against the normative mean
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Table 4. Parent-reported adaptive and psychosocial functioning
Adaptive Functioning a

N

Mean ± SD

Range

t†

p

N (%) 1 SD

N (%) 2 SD

Adaptive Composite

28

78.89 ± 15.88

51 – 118

-7.03

<.001

6 (21.5)

9 (32.1)

Social Composite

29

87.97 ± 16.06

59 – 124

-4.04

<.001

8 (27.6)

5 (17.2)

Communication Composite

23

87.13 ± 17.83

55 – 115

-3.46

.002

6 (26.1)

4 (17.4)

Daily Living Composite

23

83.48 ± 15.13

58 – 118

-5.24

<.001

9 (39.1)

4 (17.4)

Motor Skills Composite

20

83.70 ± 15.57

60 – 115

-4.68

<.001

6 (30.0)

4 (20.0)

N (%) ≥ 60

N (%) ≥ 70

Psychosocial Functioningb
Internalizing Behavior

14

53.50 ± 11.48

37 – 73

1.14

.28

3 (21.4)

1 (7.1)

Externalizing Behavior

14

55.00 ± 10.21

35 – 73

1.83

.09

5 (35.7)

1 (7.1)

Aggression

14

55.07 ± 6.12

41 – 65

3.10

.008

4 (28.6)

0 (0)

Anxiety

14

51.79 ± 7.06

43 – 73

0.95

.36

0 (0)

1 (7.1)

Withdrawal

14

56.79 ± 14.27

40 – 91

1.78

.10

2 (14.3)

2 (14.3)

Somatization

14

55.00 ± 8.71

43 – 80

2.15

.05

1 (7.1)

1 (7.1)

Attention Problems

14

57.57 ± 8.91

50 – 73

3.18

.007

1 (7.1)

3 (21.4)

Pervasive Developmental Problems

13

60.77 ± 11.51

48 – 82

3.38

.006

2 (15.4)

3 (23.1)

a Standard

score: normative mean = 100, SD = 15; 1 SD < 85, 2 SD < 70

b T-score:

normative mean = 50, SD = 10

† One-sample t-test against the normative mean
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